A method for high-throughput cloning and analysis of short hairpin RNAs (shRNAs) is described. Using this approach, 464 shRNAs against 116 different genes were screened for knockdown efficacy, enabling rapid identification of effective shRNAs against 74 genes. Statistical analysis of the effects of various criteria on the activity of the shRNAs confirmed that some of the rules thought to govern small interfering RNA (siRNA) activity also apply to shRNAs. These include moderate GC content, absence of internal hairpins, and asymmetric thermal stability. However, the authors did not find strong support for positionspecific rules. In addition, analysis of the data suggests that not all genes are equally susceptible to RNA interference (RNAi). (Journal of Biomolecular Screening 2006:236-246) 
INTRODUCTION

R
NA INTERFERENCE (RNAi) is a form of posttranscriptional gene silencing, induced by short (~21-bp) double-stranded RNA sequences that are complementary to the mRNA of the silenced gene. 1, 2 Many naturally occurring short RNAs, termed micro RNAs (miRNAs), have been identified and shown to play active roles in regulating gene expression, especially in development. 3 The apparent effectiveness and specificity of RNAi have made it of considerable interest. Moreover, the discovery that RNAi can be induced by synthetic sequences has opened the possibility of developing simple methods for gene inactivation in mammalian somatic cells. 2, [4] [5] [6] Sequences that induce RNAi can be provided to cells as either short double-stranded, in vitro-synthesized RNA oligonucleotides (siRNAs) 2 or short hairpin RNAs (shRNAs), expressed stably in cells from specialized DNA-based vectors. 6, 7 Presumably, shRNAs are converted to siRNA-like molecules in the cell. It has recently been suggested that this can occur through both dicerdependent and dicer-independent pathways. 8, 9 Ultimately, siRNAs and shRNAs exert their action on target mRNAs through incorporation into a multisubunit complex termed RISC (RNA-induced silencing complex). When charged with siRNA, RISC can induce cleavage or translational suppression of the siRNA-specified mRNA. 10, 11 Significantly, not all siRNA or shRNA sequences are equally effective. Hence, much effort has focused on defining criteria for effective design, particularly of siRNAs. [12] [13] [14] [15] [16] [17] [18] [19] Common findings from these studies include a requirement for differential thermal stability in the ends of the siRNA duplex, first suggested by Schwarz et al. 16 A benefit to having a moderate GC content in the siRNA duplex was also identified. Some authors have suggested the importance of "position-specific" criteria. However, in contrast to the physical criteria, there has not been strong agreement on these. 12, 19 Design criteria for shRNAs have been less well characterized. 20 This may reflect the additional effort to make vectors expressing shRNAs. Although siRNAs can be readily obtained commercially and used directly, oligonucleotides encoding shRNAs must first be cloned into an expression vector. However, shRNAs hold considerable potential advantage over siRNAs because they can be stably expressed, permitting long-term studies in both cell culture and animal models. 5, 21 Moreover, shRNA expression can be controlled by inducible promoters, allowing for studies in which constitutive knockdown of the gene of interest would be toxic to the cell. [22] [23] [24] [25] [26] Thus, there is a need to define criteria for the effective design of shRNAs and to simplify their cloning. Moreover, although current siRNA design criteria improve the odds of obtaining efficacious siRNAs, 12, 16 identification of the best siRNA or shRNA against a gene still requires functional validation. Therefore, there remains a need for simplified methods to screen multiple siRNAs and shRNAs for efficacy.
To address these questions, we have developed a high-throughput method for the rapid construction and screening of shRNA expression cassettes and used it to analyze factors affecting shRNA efficacy over a set of 116 genes. Several features important to shRNA design were identified, furthering the information previously published for siRNAs. [12] [13] [14] [15] [16] [17] [18] [19] 
METHODS
Fusion-protein expression vector construction
Full-length, sequence-verified open reading frames (ORFs) for all 133 genes used in this study are part of a collection of more than 1600 human ORFs (Creator Clone Collection) available from Open Biosystems (Huntsville, AL). All sequence data on these ORFs are available in GenBank (see also Supplemental Table 1 ; see http://jbx.sagepub.com/cgi/content/full/11/3/236/DC1).
Each ORF is cloned into a specialized cloning vector (pDNRDual, Clontech Laboratories, Mountain View, CA) that enables rapid transfer of the ORFs to appropriately designed expression vectors using Cre/LoxP-based recombination. To enable fusions to peptide reporters at the C-terminus of the protein, each ORF was cloned into pDNR-DUAL such that the natural stop codon was removed and replaced with a codon for leucine.
To express the proteins of interest as fusions to a reporter tag, the ORFs were transferred by Cre/LoxP-based recombination from the pDNR-Dual backbone into an expression vector that placed the reporter tag in-frame and C-terminal to the gene of interest (Fig. 1A,B) . A synthetic intron between the end of the gene and the start of the tag is removed in vivo by cellular splicing machinery, generating an expressed mRNA encoding the protein of interest fused at its C-terminus to the reporter. The reporter tag used was a modified alpha fragment of β-galactosidase, ProLabel (DiscoveRx, Fremont, CA). To ensure that expression of the ProLabel tag was strictly dependent on expression of the protein of interest, it had been cloned into the expression vector (pLPS-3′PL; Clontech Laboratories) lacking its own initiation codon.
Following recombination and transformation, colonies were screened for recombinants by triplex PCR using the following primers (CMV1: 5′ ACTCCGCCCCATTGACGCAA, PCP2: 5′ TCCGCTCATGAGACAATAACC, PCP3: 5′ CACCTTGTC GCCTTGCGTAT, SacB forward: 5′ GACGATTGA CGGCATTACGT, SacB reverse: 5′ TGCCTTTGA TGTTCAGCAGG). Expected PCR products are 269 bp for nonrecombinant pDNR-Dual (SacB forward/SacB reverse), 177 bp for nonrecombinant acceptor vectors (CMV1 and PCP2), and 661 bp for the recombinants (PCP2 and PCP3).
Design of shRNAs
Four shRNA-encoding sequences were selected for each gene tested. Based on previous studies, which have shown efficient knockdown using shRNAs with 19-bp stems, 4, 7, 27, 28 we chose to use a stem length of 19 bases for our shRNA designs. Specificity of
FIG. 1.
Constructs and methods used to measure short hairpin RNA (shRNA) knockdown activity. (A) Diagram of the cotransfection process used to assess shRNA knockdown activity. An expression plasmid for the gene of interest fused to a reporter sequence is cotransfected with an expression cassette encoding either a specific shRNA (right) or an irrelevant sequence (left). Gene expression changes are measured by comparing the reporter's expression in both sets of transfected cells. (B) Detailed structure of the gene expression constructs. The presence of splice donor (SD) and the splice acceptor (SA) sites creates an artificial intron that is removed in vivo by the cellular splicing machinery, so that the protein of interest is expressed as a fusion to the reporter sequence.
shRNA 19-mer sense oligonucleotides was confirmed by sequence similarity search against the National Center for Biotechnology Information (NCBI) collection of human genes (RefSeq release, November 2003). Both the sense and antisense orientations of each sequence were searched to reduce the possibility of off-target effects caused by homology of either strand to occult target mRNAs. However, it should be stressed that an important caveat to any RNAi experiment is that computational analysis cannot exclude the possibility for off-target effects. Thus, it is important to always screen, and ultimately to use, more than 1 shRNA against a gene of interest to reduce the likelihood that observed phenotypes are due to off-target effects of the siRNAs or shRNAs. All selected oligonucleotide sequences were free of genomic repeats and had no similarity longer than 13 bases to any secondary target mRNA in the collection in either the sense or antisense strand. In addition, an effort was made to allocate each of the 4 shRNA sequences evenly throughout the mRNA length as far from each other as possible within the coding region of the target mRNA.
Initially, shRNA oligonucleotides were designed using the basic rules described by Tuschl and collaborators (see http:// www.rockefeller.edu/labheads/tuschl/sirna.html) using an online design tool (http://bioinfo.clontech.com/rnaidesigner/). Based on our initial results and those published by others, 12, 16, 17 we developed a multistep selection procedure implementing a set of sequence constraints on all gene-specific 19-mers identified. These constraints were as follows: 1) no stretch of the same base longer than 4 was permitted, and 2) all 4 bases had to appear at least once but not more than 10 times in any oligonucleotide. In addition, a low-complexity filter was applied to eliminate sequences of alternating nucleotides (e.g., ACACACAC or AACCAACC). Filtered sequences were then ranked according to GC-content (min = 30%, opt = 40%, max = 52%), Tm of sense-antisense RNA duplex (min = 50°C, opt = 55°C, max = 60°C), and Tm of any internal RNA hairpins (max = 50°C). Tm values were calculated using the nearest-neighbor model according to Mathews et al. 29 It has been shown that siRNAs having a lower thermal stability at the 3′ end of the sense strand with respect to the 5′ end promote incorporation of the desired antisense strand into the RISC complex, thus showing improved knockdown efficacy compared to sequences lacking such thermal asymmetry. 16 As a simple approach to preferentially selecting sequences for shRNAs with similar asymmetry in their thermal stability, sequences with an A or U in positions 17 to 19 of the sense oligonucleotide were preferentially selected over others. Overall, the ranking system did not strictly enforce selection of oligonucleotides within the optimal parameters but rather provided a basis for compromise when no "ideal" sequence could be found. (See Discussion section for further analysis of shRNA sequence design.)
For each 19 base pair sequence chosen, a pair of complementary DNA oligonucleotides of 65 to 67 bases in length encoding the required shRNA sequence was synthesized and PAGE purified (Sigma-Genosys, Woodlands, TX; or Integrated DNA Technology, Coralville, IA). Each oligonucleotide pair included the following elements: a Bam HI overhang on the 5′ end of the duplex, the 19 nucleotides of the shRNA sense strand, a loop sequence (top strand: 5′ TTCAAGAGA), the 19 nucleotides of the shRNA antisense strand, a Pol III termination site of 6 consecutive thymidine residues, an Nhe I or Mlu I site to verify cloned inserts, and an Eco RI overhang on the 3′ end of the duplex. It has been shown that Pol III transcription initiates only from purines. 30 Thus, if the designed 19-nucleotide shRNA sequence did not start with a guanine or adenine, an extra guanine residue was added to the 5′ end of the shRNA sense strand, and this 20-nucleotide sense strand was then used in place of the 19 base sequence as a basis for oligo design. Retrospectively, we examined the effect of this additional guanine by comparing the knockdown activity of 3 shRNAs with or without the initial guanine (see Supplemental Fig. 3 ; see http:// jbx.sagepub.com/cgi/content/full/11/3/236/DC1). In all 3 cases, removal of the guanine resulted in a dramatic decrease in shRNA efficacy, suggesting that, as reported, 30 Pol III-based transcription shows a strong preference to start at a purine.
Generation of shRNA plasmids and expression cassettes
Annealed oligonucleotides encoding shRNAs were either cloned by standard ligation methods into an shRNA expression vector (pSIREN-DNR; Clontech Laboratories) or used to generate linear shRNA expression cassettes (SECs) (schematic explanation in Supplemental Fig. 1 ; see http://jbx.sagepub.com/cgi/content/ full/11/3/236/DC1). For SEC production, annealed oligonucleotides encoding shRNAs were ligated into pSIREN-DNR, as described in the Clone & Confirm Kit user manual (Clontech Laboratories). Then, 1 µL of the ligation was amplified by PCR using the following vector-specific primers: fwd = 5′-CCTGCGTTATCCCCTGATTCTGTG′; rev = 5′-CAGGGCGGGGCGTAATTTGATATC. Annealing was done at 60°C for 40 s and extensions at 72°C for 1 min, for a total of 30 cycles. For high-throughput cloning, PCR reactions were performed in parallel in a 96-well plate using a lyophilized Taq polymerase enzyme formulation (SPRINT Advantage 96-well plates; Clontech Laboratories).
For each shRNA expression vector cloned, a total of 3 colonies were picked and screened by restriction digest for the presence of an insert using either Nhe I or Mlu I. One insert-containing clone for each shRNA was then also verified by sequencing. SECs were screened by size for the presence of the insert using a 2% agarose gel. For transfections, plasmids were purified using the NucleoSpin ® plasmid purification kit (Clontech Laboratories), whereas SECs were purified following PCR using the NucleoSpin ® Extract Kit (Clontech Laboratories). For both plasmids and SECs, expression of the shRNA was driven by the human U6 promoter (accession: M14486).
31,32
Analysis of knockdown by transient cotransfection
Transient transfections to measure either protein expression or knockdown were done using HEK293 cells seeded 24 to 48 h prior to transfection in either 12-well or 96-well plates (Fig. 1 ). Cells were seeded at a density of either 2-2.5 × 10 5 cells/well (12-well plates) or 2-3 × 10 4 cells/well (96-well plates). For assays done in 12-well plates, transfections were done using the CalPhos Mammalian Transfection Kit (Clontech Laboratories), according to the protocol in the user manual. In 12-well plates, 125 µL transfection mix containing 800 ng of total DNA was added to each well containing 1 mL Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 mM sodium pyruvate, penicillin/streptomycin, and 10% fetal bovine serum. In 96-well plates, transfections were done using Lipofectamine 2000 ™ (Invitrogen, Carlsbad, CA), following the manufacturer's instructions, with a total of 150 ng DNA per well. In all cases, media were replaced 6 h after transfection, and expression measurements were performed after 48 h. Except where noted, all transfections were done in triplicate, and data are presented as the average of triplicate transfections ± standard deviation.
For expression experiments, DNAs were mixed at a mass ratio of 5:2 (fusion protein/transfection control). For knockdown experiments, DNAs were mixed at a mass ratio of 5:2:1 (fusion protein/ transfection control/shRNA). Previous experiments (data not shown) had demonstrated that efficacious shRNAs caused knockdown in transient-transfection experiments even when the vector expressing them was transfected at a low-mass ratio in comparison to the target gene expression construct. Thus, to bias experiments in favor of identifying highly effective shRNAs, transfections were done using an excess of the target construct DNA relative to the shRNA expression vector.
Reporter expression measurements
To quantify expression of the fusion proteins, β-galactosidase activity was measured using the ProLabel Chemiluminescent Detection Kit (Clontech Laboratories), following the manufacturer's instructions. For all experiments, variations in transfection efficiency were normalized by cotransfecting the experimental plasmids with a secondary reporter. Mostly, pCMV-SEAP (Clontech Laboratories) was used as the secondary reporter. In this case, culture medium was collected from the cells 48 h posttransfection and assayed for secreted alkaline phosphatase (SEAP) activity using the Great EscAPe SEAP Chemiluminescent Detection Kit (Clontech Laboratories). In some instances, a cellular luciferase reporter was used (pCMV-Luc), and luciferase activity was measured in the cell lysates using firefly luciferin (Promega, Madison, WI). Finally, in some experiments, a secreted luciferase reporter was used with coelenterazine (coelenterate luciferin, Promega) as substrate in a reaction as previously described. 33 All chemiluminescent signals were quantified on a Monolight 3096 plate luminometer (BD Biosciences Pharmingen, La Jolla, CA).
Measurement of protein knockdown
Percentage knockdown induced at the protein level by each shRNA was calculated by taking the normalized ProLabel activity measured in cells transfected with the shRNA (SEC or plasmid) specific for the gene of interest and comparing it to the ProLabel activity measured in cells transfected with an "irrelevant" shRNA directed against luciferase. The sequence of the sense strand of this "irrelevant" shRNA is 5′ GTGCGTTGCTAGTACCAAC.
Statistical analysis
Statistical analysis of the effects of various design criteria on knockdown activity was done using the rank-sum test. This test was chosen because it does not require assumptions to be made regarding the normality of the underlying sample distribution. Student t-test was used to assess whether the effectiveness of each shRNA could be considered independent and to test the significance of the difference in thermal asymmetry between effective and ineffective shRNAs.
Real-time quantitative PCR assays
In some cases, knockdown was measured by real-time quantitative PCR in addition to the ProLabel reporter assay. To do this, cells were removed from the culture plate with Dulbecco's phosphate-buffered saline (PBS) supplemented with 1 mM EDTA and split into 2 equal portions. One portion was then lysed and assayed for ProLabel reporter activity, as described above. Total RNA was extracted from the 2nd portion with the NucleoSpin II RNA extraction kit (Clontech Laboratories). From this RNA, 1st-strand cDNA was generated by random-primed reverse transcription using PowerScript reverse transcriptase (Clontech Laboratories). Expression of mRNA was then determined by real-time quantitative PCR using a technology based on the catalytic activity of a DNAzyme 34, 35 (QZyme technology, Clontech Laboratories). Primer pairs were designed around the shRNA target site in the gene of interest to ensure that the shRNA-induced mRNA cleavage was directly measured. All assays were run in duplex mode on an ABI 7700, using primers to Ribosomal Protein, large, P0 (RPLP0), to normalize gene expression. Full details of the method can be found at the following URL: http://www.clontech.com/clontech/ techinfo/manuals/PDF/PT3780-1.pdf. Knockdown activity was determined by comparing normalized mRNA expression in the presence of the shRNA of interest to that in the presence of an irrelevant shRNA.
Western blot analysis
Forty-eight hours posttransfection, cells were lysed, and the lysates were used either for measurement of ProLabel activity or
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Western blot analysis using specific antibodies for STAT1, STAT6, MAPK14, and β-actin (BD Biosciences Pharmingen). Briefly, about 15 µg per lane of each lysate was separated on 4% to 20% gradient 10-well minigels (Invitrogen), transferred to polyvinylidene difluoride (PVDF) membranes, and probed with each antibody at the recommended optimal concentration using a standard Western blot protocol.
RESULTS
Use of the ProLabel tag to screen for knockdown
Key to screening large numbers of siRNA or shRNA sequences for efficacy are simple methods for measuring loss of expression of the target genes. Real-time PCR methods, because they are amenable to high-throughput screening (HTS), have been a method of choice. However, such methods only measure knockdown at the mRNA level. Moreover, because cleaved mRNA fragments may be stable, real-time PCR methods require the use of specific primers that flank the sequence targeted by the siRNA/shRNA, making testing of multiple sequences expensive. Methods based on analysis of mRNA expression level are also inappropriate for analysis of sequences that inhibit protein expression through mechanisms other than mRNA cleavage, such as the inhibition of translation induced by micro RNAs and, in some cases, siRNAs. 36 Because the ultimate goal of generating an siRNA or shRNA sequence is to induce protein knockdown, it is desirable to screen such sequences for efficacy at the level of protein expression. To do this in high throughput, however, requires an assay of protein knockdown that can be standardized to all proteins under study. The most straightforward approach is to express the proteins of interest fused to a suitable reporter or tag. Fluorescent protein tags are an obvious choice because of their readily detectable intrinsic fluorescence. 37 However, quantification of the fluorescent signal, typically done by flow cytometry, is not readily adapted to high-throughput automation. Reverse-transfection methodologies can also be used to screen knockdown of fluorescent protein-tagged constructs. 38, 39 Although such methods are amenable to high throughput, they require robotic arraying equipment. In addition, fluorescent protein reporters may lack sensitivity compared to enzymatic reporters. Moreover, function of either the protein of interest or the fluorescent protein may be adversely affected by the size of the fusion, thereby hindering analysis. Alternatively, short epitope tags, such as the HA, Myc, and FLAG tags, can be used. The small size of these tags makes them less likely to interfere with the function or expression of the protein under study. However, because they have no intrinsic activity, protein amount must be measured by Western blot, which is both hard to quantify and refractile to high-throughput analysis. To address this concern, we have focused on a small, 55-amino acid, N-terminal fragment of β-galactosidase (ProLabel, DiscoveRx) that can be used to reconstitute the enzymatic activity of an inactive C-terminal (Ω) fragment (enzyme acceptor [EA] ). This restored activity is readily quantified using standard chemiluminescent β-galactosidase substrates. [40] [41] [42] Three features of this assay make it especially useful for high-throughput analysis. First, it is a homogeneous assay. Second, all genes can be analyzed under the same conditions. Finally, the signal generated can be read in any standard plate-based luminometer.
To test the effectiveness of the ProLabel tag as a measure of protein knockdown, we generated ProLabel-tagged expression constructs for 17 genes and confirmed expression by transient transfection of HEK293 cells (data not shown). Using rules described by Tuschl et al. (see Methods), 4 shRNAs were then designed against each of the genes (total of 68 shRNAs) and cloned into a prelinearized shRNA expression vector (pSIREN-DNR, Clontech Laboratories). Clones were verified by restriction digestion and sequencing.
Each cloned shRNA was then screened for efficacy by cotransfection with the respective ProLabel fusion construct (see Methods and Fig. 1 ). As shown in Figure 2 , some shRNAs were highly effective (knockdown activity > 70%), whereas others had less effect. In the case of some genes (e.g., SMARCE1), lack of knockdown may be attributed to poor expression of the ProLabel construct, making accurate measurement of knockdown difficult. Another possible explanation for the failure of some shRNAs to induce knockdown is that the 19-bp stems of the shRNAs are too short for effective processing into siRNAs. To address this concern, we sought to test the effect of increasing stem length on the efficacy of poorly functional shRNAs. Stem lengths of 21, 23 , and 27 bases were tested for several different shRNAs against 7 of the genes. However, no consistent improvement in knockdown activity was observed (see Supplemental Fig. 2 ; see http:// jbx.sagepub.com/cgi/content/full/11/3/236/DC1). This result is consistent with the findings of other researchers, 4,7,27,28 although recently, 2 publications have presented evidence suggesting that longer stems may be beneficial. 8, 9 Nonetheless, Brummelkamp et al. 7 have shown that shRNAs with 19-bp stems are rapidly converted in the cell to siRNA-like molecules of approximately 19 bases in length. Based on these results, we conclude that 19 base stems are adequate and that lack of activity is not simply due to inefficient processing of the shRNAs. For reasons that remain unclear, some shRNAs appeared to induce expression of the gene of interest (e.g., certain shRNAs against ZNF237 and RAC2). Overall, 30 of the shRNAs (44%) reduced gene expression by at least 50%. Of these, 14 (21%) induced knockdown by at least 70%. In total, 9 genes were identified for which at least 1 shRNA gave a knockdown of at least 70%, indicating that for some genes, multiple highly effective sequences were obtained (e.g., PRKAR2A). This observation is considered further through statistical analysis in the discussion.
Comparison of ProLabel assay with Western blot analysis
To confirm that loss of ProLabel activity is due to protein loss, knockdown of 3 proteins (STAT1, STAT6, and p38α/MAPK14) was reassessed by Western blot analysis. In this case, the respective ProLabel fusion construct for each of the proteins was cotransfected with either the irrelevant shRNA or the most effective of the 4 shRNAs originally tested. In all cases, knockdown observed by Western blot was consistent with that determined using the ProLabel assay (compare Figs. 2 and 3) , being robust in the case of STAT1 and STAT6 and marginal for MAPK14. None of the experimental shRNAs had any observable effect by Western blot on the level of endogenous β-actin expression, used as a loading control (Fig. 3) . The slight apparent decrease in the expression of β-actin in the irrelevant shRNA control lane for STAT1 is presumably a loading artifact because the same irrelevant shRNA control had no effect on the β-actin signal in the other 2 control lanes. In addition, no effect of the nonspecific shRNA compared to mock transfected cells was seen (data not shown).
Comparison of ProLabel and real-time quantitative PCR measurements
RNAi induced by siRNAs or shRNAs is believed to occur primarily through cleavage of the mRNA, preventing protein translation. Thus, we also wanted to confirm that the ProLabel assay data reflected knockdown at the mRNA level. We therefore cotransfected cells with a set of 15 ProLabel fusion vectors and corresponding shRNA expression vectors. After 48 h, the cells were collected, and a portion was used to quantify mRNA expression levels by real-time RT-PCR. The remaining portion was used for ProLabel assays. In general, knockdown observed at the mRNA level showed good correlation with the ProLabel data (Fig.  4) . Protein knockdown levels were mostly lower than those obtained for mRNA, consistent with protein loss being secondary to mRNA cleavage. For 8 of the 15 genes tested (53%), the difference between the real-time PCR result and the ProLabel data was less than 15%. Another 4 genes (27%) showed less than 35% difference. Only 3 genes tested showed differences of more than 35%. All of these had either very low ProLabel expression (MDM2, SMARCE1) or low mRNA expression (SMARCC2, ZNF274), which may have confounded the accuracy of either measurement in these cases.
High-throughput analysis of 464 shRNAs against 116 genes
Although several large library collections of shRNAs targeting most, if not all, human and mouse genes have been generated, [43] [44] [45] Screening 11(3); 2006 www.sbsonline.org 241
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FIG. 3.
Analysis of knockdown activity by Western blot. STAT1-, STAT6-, and MAPK14-ProLabel (PL) fusions were cotransfected into HEK293 cells with either a relevant (r) or irrelevant (i) short hairpin RNA (shRNA) expression plasmid. After 48 h, total cell lysates were prepared and subjected to Western analysis. Arrow: STAT1-, STAT6-or MAPK14-specific bands. As a control for loading, the blot was also probed with an antibody against β-actin (actin). The images shown were cropped from the image of the entire gel lane; no other immunoreactive bands were seen. Knockdown percentages, as determined by parallel ProLabel activity assays, were 89%, 86%, and 44% for STAT1, STAT6, and MAPK14, respectively.
FIG. 2.
Initial validation of the ProLabel assay. Transfection-normalized knockdown activity is given for each of 4 short hairpin RNAs (shRNAs) designed against 17 genes. Averages of triplicate data are shown with standard deviations.
individual functional validation of specific shRNAs on a large scale has not been previously presented. This is likely due to the difficulty in cloning multiple shRNAs in parallel and the lack of high-throughput methods to screen either shRNAs or siRNAs for knockdown activity. The ProLabel activity assay described here provides a simple method to quantify knockdown at the protein level that is amenable to HTS. However, the process of cloning and sequencing individual shRNA expression plasmids used in the experiments described above is too cumbersome for high-throughput analysis. To address this remaining bottleneck, we developed a PCR-based method for generating linear shRNA expression cassettes that dramatically simplifies the cloning and screening of shRNAs. (For details, see Methods and Supplemental Fig. 1 ; see http://jbx.sagepub.com/cgi/content/full/11/3/236/DC1.) In contrast to previous methods that use PCR primers encoding the shRNA itself, 46 the current method uses an initial optimized ligation step to clone the DNA oligonucleotide duplexes encoding each shRNA into a prelinearized shRNA expression vector. Then, rather than transforming the ligations to generate individual clones, an aliquot of the ligation is instead used for PCR with vector-specific primers flanking the cloning site and the U6 promoter, so as to generate a linear SEC (see Methods and Supplemental Fig. 1 ; see http://jbx.sagepub.com/cgi/content/full/ 11/3/236/DC1). This method greatly simplifies the PCR step and increases the yield of PCR product (data not shown) compared to previous methods, 46 as well as providing various downstream functional advantages (see also Discussion section).
Using this method, we generated a set of SECs for 464 shRNAs targeting 116 genes (4 shRNAs per gene). The shRNAs were chosen using a modified set of design criteria, as described in the Methods section, taking into account observations from our original analysis of 17 genes and data published by others. 12, 16 These were then screened for efficacy against the genes of interest using the ProLabel assay. To expedite screening, each shRNA was first tested by transfection of cells in a single well of a 96-well plate. About half were then rescreened in triplicate to generate average knockdown percentages with a standard deviation. The results of this analysis, summarized in Figure 5 , show a clear improvement in the shRNA design success rate, compared to the initial test of 68 shRNAs (p = 0.0136 by rank-sum comparison). In particular, we see a marked increase in the percentage of shRNAs that induce a knockdown of greater than 70%-from 21% originally to 31% in the high-throughput set. The percentage of shRNAs with knockdown activities greater than 50% is also increased-from 44% to 61%. Detailed results for each shRNA are provided in Supplemental Table 1 (see http://jbx.sagepub.com/cgi/content/full/11/3/ 236/DC1).
DISCUSSION
High-throughput shRNA screening
RNAi presents a powerful tool for analysis of gene function. In particular, shRNA expression systems enable the generation of both stable cell lines and animal models lacking expression of targeted genes. 5, 21 Critical for success is the ability to design and validate highly effective shRNA sequences. We have described a method for the rapid cloning and screening of shRNAs and used it to test the functionality of 464 shRNAs against 116 genes. Using this method, it is possible for a single researcher to readily screen approximately 100 to 200 shRNAs per week.
There are several advantages to the approach that make it amenable to high-throughput analysis. In particular, there are several benefits to the PCR-based method we have described for generating shRNA expression cassettes by PCR compared to earlier methods. 46 These improvements greatly simplify the process of generating SECs as well as improve the robustness of the PCR. First, by using PCR primers on the vector arms rather than primers that encode the shRNA itself, the same primers and amplification conditions can be used for all constructs, making it possible to use a single PCR master mix to generate all SECs. This dramatically increases the robustness of the cloning and makes the method readily amenable to high-throughput shRNA screening. Second, previous methods require either multiple rounds of PCR or the use of extremely long (> 70-bp) primers that encode the complete shRNA hairpin as well as the start of the Pol III promoter sequence. Such primers are expensive to make, requiring high-performance liquid chromatography (HPLC) or PAGE purification to obtain high-quality product. In addition, the hairpin structure of these primers greatly hinders their ability to amplify (data not shown). Finally, in the current approach, flanking sequences of several hundred bases can be added directly to the SEC. This effectively limits exonuclease degradation of the shRNA sequence, without the need to use modified primers to enhance SEC stability (data not shown).
In addition to simplifying the generation of the SECs, the current method offers additional downstream functional advantages. First, once an SEC has been tested for knockdown activity, an expression plasmid encoding the specific shRNA can be obtained simply by transforming the original ligation mix; no additional cloning steps are required. In contrast, previous methods require that the SECs be either TA cloned or ligated into a prelinearized vector. Second, with appropriate positioning of the amplification primers on the vector backbone, one can generate SECs that contain other components in addition to the shRNA expression cassette, such as a fluorescent reporter for use as a transfection control (see Supplemental Fig. 1 ; see http://jbx.sagepub.com/cgi/ content/full/11/3/236/DC1).
The ProLabel assay for knockdown activity also affords a number of advantages. First, knockdown is quantified at the protein level using a homogeneous enzymatic assay that can be read on standard plate-based luminometers. Second, the same assay can be used for every siRNA or shRNA, irrespective of where they lie within the target sequence.
Screening of tagged proteins does require the availability of the coding sequence for the gene of interest, or at least some fragment of it. However, postgenome efforts to generate large collections of expression-ready open-reading frames of cDNAs for many species are making this less of a concern. [47] [48] [49] [50] The use of a tagged reporter construct also requires detectable expression of the target protein. However, most of the proteins tested here were expressed well as ProLabel fusions, with fewer than 10% having ProLabel activities less than 5-fold above background.
In preliminary studies, 20 proteins were also tested as fusions to a fluorescent protein tag. For this set, ProLabel fusions were more readily detectable over background signal in all but 1 case (data not shown), supporting the view that a smaller tag has less impact on the functionality and expression of the protein of interest.
A final but significant caveat to the use of a reporter as a surrogate for the endogenous target is the possibility that shRNAs that are effective against the reporter construct may not be active against the endogenous mRNA. Although we cannot comprehensively address this concern, we have tested 2 shRNAs validated by this method against their endogenous targets (p53 and STAT1) and found them to be as effective. In 1 case, we have obtained stable knockdown data with the shRNA for a period of 7 months in culture (manuscript in preparation).
Design criteria for shRNA and the importance of screening
Several authors have published criteria for rational siRNA design. [12] [13] [14] [15] [16] [17] [18] [19] However, little has been published on factors affecting shRNA design. Our screening of 464 shRNAs targeting 116 genes is, to our knowledge, the largest data set published examining the efficacy of either siRNAs or shRNAs. To identify criteria important for shRNA design, we have analyzed the data from our set retrospectively for the impact of different design criteria on shRNA efficacy. We included data from all the shRNAs in this analysis, even if the expression of target gene was very low, because removing the low expressers from the data set (total of 56 shRNAs against 14 genes) did not materially affect the results.
As previously described by others for siRNAs, [12] [13] [14] [15] [16] [17] [18] [19] we find that both high GC content (> 52%) and the presence of internal hairpins have a strong negative impact on shRNA efficacy (p = 0.007 and p = 0.025, respectively, as calculated using the rank-sum test). The significance of various selection criteria on shRNA efficacy is summarized in Table 1 .
We also find support for asymmetry in the relative stabilities of the 5′ and 3′ ends of the predicted siRNA duplexes, as described by Schwarz et al., 16 with the calculated ∆G for the 3 bases at the 5′ end of the sense strand being on average 1.4 kJ/mol lower than that calculated for those at the 3′ end in the 146 shRNAs that had knockdown activities greater than 70%. In contrast, for the 146 least effective shRNAs, this difference was only 0.9 kJ/mol (p = 0.003, Student t-test).
In general, we do not find strong support for "position-specific" criteria (see Table 1 ). However, we did find a bias toward the presence of "A" or "U" bases and the absence of "G" and "C" at the 3′ end of the sense strand in shRNAs with greater than 70% knockdown activity. Presumably, this is a reflection of the positive impact of differential stability on shRNA activity, discussed above. 16 It should be noted that there is little concordance among the position-specific rules described to date. 12, 13, 17, 19 These studies have typically used limited sets of genes to test design criteria. Thus, it is possible that the position-specific rules may be artifacts resulting from sequence bias. We have likely avoided such bias in the data presented here by analyzing multiple shRNAs against more than 100 different genes. In this respect, it is interesting to note that the most strongly supported "position-specific" criterion is an A at position 6 in the sense strand, the presence of which appears to be associated with increased knockdown efficacy (p = 0.018; see Table  1 ). We have no biological explanation for why this residue should have an impact on knockdown. However, the potential significance of this criterion was initially suggested by Amarzguioui and Prydz, 19 who analyzed siRNA data from a wide set of different genes.
For each of the criteria discussed above, we also assessed the significance when mapped against a randomly resorted set of the shRNAs. In this randomized set, none of the criteria rose to the level of significance (p = 0.163-0.671). It should be stressed that none of the physical criteria (GC content, internal hairpins, and asymmetry) that appear to affect shRNA activity, either individually or combined, guarantees the identification of a highly effective shRNA. Rather, they serve only to improve the likelihood of an shRNA being effective, underscoring the utility of simple screening methods to validate shRNA or siRNA function, as described here.
Are genes equally susceptible to RNAi?
For RNAi to achieve its full promise as a tool for simplified inhibition of protein expression, all genes should be susceptible to inhibition by siRNAs or shRNAs. If all genes are indeed equally susceptible to RNAi, then the knockdown activity of any given shRNA against a gene of interest should be independent of the efficacy of any additional shRNA designed against the same gene. Although there is anecdotal evidence that different genes may be differentially susceptible to RNAi, a rigorous test of this hypothesis has not been possible previously because of the use of limited data sets. 12, 19 The large data set presented here has allowed us to examine this important question. As shown in Figure 5B , the overall probability that any one of the predesigned shRNAs described here will have a knockdown activity of greater than 70% is 0.31. If the activities of individual shRNAs are truly independent, then for a set of 4 shRNAs designed against the same gene, the likelihood that at least 1 of the shRNAs has a knockdown activity of greater than 70% is theoretically 0.78 (i.e., 1-(1-0.31) 4 ). Thus, we would expect to find about 90 genes (0.78*116) having at least 1 shRNA with a knockdown activity of greater than 70%. In contrast, only 74 genes fit this criterion, suggesting that the activities of shRNAs designed against the same gene are not independent. Analyzed another way, we find that if the knockdown activity of an shRNA, chosen at random, is greater than 70%, then for the remaining 3 shRNAs designed against the same gene, the chance that at least one other will have a knockdown activity of greater than 70% is 0.82 (p = 0.006; Student t-test). In contrast, when the 1st shRNA chosen has a
